IDEAYA Biosciences (IDYA) Total Liabilities (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Total Liabilities data on file, last reported at $93.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 21.66% year-over-year to $93.1 million; the trailing twelve-month figure through Mar 2026 stood at $93.1 million (up 21.66% YoY), and the FY2025 full-year result was $86.4 million, up 33.02% from the prior year.
• Total Liabilities rose to $93.1 million in Q1 2026, from $86.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $93.1 million in Q3 2025 to a low of $24.9 million in Q3 2023.
• A 5-year average of $56.1 million and a median of $59.5 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities slumped 62.22% in 2023 and jumped 191.83% in 2025, its largest moves.
• Tracing IDYA's Total Liabilities over 5 years: stood at $38.5 million in 2022, then retreated by 26.71% to $28.2 million in 2023, then jumped by 130.09% to $64.9 million in 2024, then soared by 33.02% to $86.4 million in 2025, then rose by 7.75% to $93.1 million in 2026.
• Business Quant data shows IDYA's Total Liabilities at $93.1 million in Q1 2026, $86.4 million in Q4 2025, and $93.1 million in Q3 2025.